Experience and Acceptance of a New Organisational Model in Primary Care: Participatory Multi-professional Health Centres (EXPER-MSP)
June 2, 2026 updated by: Assistance Publique Hopitaux De Marseille
A qualitative study employing a grounded theory approach, using semi-structured interviews and focus group discussions with patients participating in the participatory scheme under investigation, as well as professionals who took part in the scheme or partners, recruited through theoretical sampling.
Inductive analysis following full transcription of the interviews.
Triangulation of the analysis by at least two researchers.
Study Overview
Study Type
Observational
Enrollment (Actual)
48
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France, 13003
- MSP Universitaire Peyssonnel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients covered by the Complémentaire santé solidaire (CSS) or the Aide médicale d'État (AME)
Description
Inclusion criteria:
- Patients aged 18 years and over;
- Patients covered by the Complémentaire santé solidaire (CSS) or the Aide médicale d'État (AME)
- Whose general practitioner (or designated referring doctor for patients covered by the AME) is one of the general practitioners at the Peyssonnel health centre;
Exclusion criteria:
- Presenting with cognitive impairments that limit comprehension;
- Refusal to participate in the study;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients covered by AME or CSS who are regularly treated within a participatory coordinated care net
|
individual and group interviews
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' experiences and care pathways
Time Frame: 1 month
|
Qualitative analysis based on patients' self-reported experiences.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 19, 2023
Primary Completion (Actual)
April 25, 2025
Study Completion (Actual)
April 25, 2025
Study Registration Dates
First Submitted
May 26, 2026
First Submitted That Met QC Criteria
June 2, 2026
First Posted (Actual)
June 8, 2026
Study Record Updates
Last Update Posted (Actual)
June 8, 2026
Last Update Submitted That Met QC Criteria
June 2, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-A00573-42
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
not decided yet
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.